Molecular biology of squamous cell carcinoma of the head and neck
about
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variantsUpdated overview of current biomarkers in head and neck carcinomaHPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesThe role of microRNA in head and neck cancer: current knowledge and perspectivesTopical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor responseClinical features and treatment strategy for HPV-related oropharyngeal cancer.HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell linesL-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.The economic burden of human papillomavirus-related precancers and cancers in Sweden.ANO1 as a marker of oral squamous cell carcinoma and silencing ANO1 suppresses migration of human SCC-25 cells.[Translational research in head and neck cancer. Biological characteristics and general aspects].Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.Molecular signatures of metastasis in head and neck cancer.Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.Increased expression of the retinoic acid-metabolizing enzyme CYP26A1 during the progression of cervical squamous neoplasia and head and neck cancer.Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains.Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomasOverexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes.Tumor necrosis factor receptor superfamily 10B (TNFRSF10B): an insight from structure modeling to virtual screening for designing drug against head and neck cancer.Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma.Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.Autophagy regulation in cancer development and therapy.Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival CharacteristicsGenome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients.Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer.Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization.Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway ActivationMiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human gliomaOPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome.The Role of p53 and MDM2 in Head and Neck Cancer.Modifiable risk behaviors in patients with head and neck cancer.N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration.p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study
P2860
Q24624194-F55E28E1-455A-4C5B-94F4-C4E0C860A96BQ26750659-647EFF71-CA1D-4622-A193-D89E2EA52450Q26752584-11CB301F-9636-410B-9DE5-8A21464406E8Q26851256-B202B128-2D3B-4807-8E49-D7E3A6782B4FQ28728905-0111DD5C-AC15-47C5-A0BD-E82FC00F1997Q30249150-21C634E9-48BF-4B12-A139-CC4B62173476Q30278790-618270BA-A4A5-4FD9-BB95-CA14219B0240Q31105430-4926576C-8674-4A39-85A5-4F6641510D72Q33834660-27027AD5-DA4A-498F-9F08-6F20A758B3F0Q33991121-D90B3F15-F960-486F-82C4-D9B89C18C917Q34000961-7FB739FE-6650-4C84-A14C-7F5F83B60CB2Q34000993-855A900A-217D-43B8-87A9-BDCF47B7C06EQ34060131-6D3C7777-3575-4DA3-AB22-1B45BD93E067Q34101582-C2C36067-C3A6-478C-84E6-C8C79252E158Q34122834-47B65827-C536-4919-9F71-39C01E09ED6CQ34346640-86B143D5-9683-47C6-A4C5-04EC79F2F156Q34617214-AE0DB5BA-76A8-4E4D-804A-0C5E884C3D0CQ34622885-3910D970-3182-478A-BE21-BD57A85B1DD2Q34722869-932A357B-BC16-4A82-AA51-C29953E8FE21Q34750450-E1BB12DD-E82E-4D81-8018-A0DE9E734AF1Q34764447-57891C0F-5488-46E5-BB59-F3DAE40673ABQ35191014-235D99FF-BA72-4A18-AC39-DC6208596141Q35220347-80EB7A01-9C0C-4EA5-9295-BCA9D9E36C60Q35232272-D53C5DC2-961C-425B-AF9D-0E7CB3C6FA55Q35550271-3C0B3EBC-6F9F-46AD-9BFA-88ACD923FF6CQ35562351-8E4DA684-AD27-475E-B9FB-662FFDDA98A2Q35670835-366679B7-CFAD-40A2-BBDB-408986C5F651Q35738663-F5F8D5C0-F51C-40DF-B892-86D9A89C343AQ35954892-4B6F09EF-6E71-4997-9E52-4BDEF66B4231Q35995194-28E7FA13-F31B-475A-A8CB-51680676765EQ35996100-86437BAF-1DBD-4510-AAC4-C04CC21B1D7FQ36097570-E6EE6E8E-433B-423A-9F39-06541C50090CQ36297745-E6F5A855-5F62-439C-A1BB-FAA0CA3A9342Q36413108-DE0BEA87-3679-4400-97A8-496535DDF9D5Q36610720-E0630470-12D9-4EDC-A603-F8DF3D4AD80CQ36857374-A1E4382B-5848-4B77-B183-56E573FD0622Q36941427-6166DCF7-ED6F-41D7-84D7-4B7B116619A5Q37012394-7F8CDE30-071B-42B6-9AAE-032D441982A7Q37021095-ACF47277-B4E6-46D9-8C38-BE03265E561EQ37105113-B36EE40A-7864-40A2-87ED-E40546263D55
P2860
Molecular biology of squamous cell carcinoma of the head and neck
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular biology of squamous cell carcinoma of the head and neck
@ast
Molecular biology of squamous cell carcinoma of the head and neck
@en
Molecular biology of squamous cell carcinoma of the head and neck
@nl
type
label
Molecular biology of squamous cell carcinoma of the head and neck
@ast
Molecular biology of squamous cell carcinoma of the head and neck
@en
Molecular biology of squamous cell carcinoma of the head and neck
@nl
prefLabel
Molecular biology of squamous cell carcinoma of the head and neck
@ast
Molecular biology of squamous cell carcinoma of the head and neck
@en
Molecular biology of squamous cell carcinoma of the head and neck
@nl
P2860
P356
P1476
Molecular biology of squamous cell carcinoma of the head and neck
@en
P2093
M Beauchemin
R C K Jordan
P2860
P304
P356
10.1136/JCP.2003.007641
P407
P577
2006-05-01T00:00:00Z